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RNA synthesisCoronavirus RNA synthesis is performed by a multienzymatic replicase complex together with cellular
factors. This process requires the speciﬁc recognition of RNA cis-acting signals located at the ends of the viral
genome. To identify cellular proteins involved in coronavirus RNA synthesis, transmissible gastroenteritis
coronavirus (TGEV) genome ends, harboring essential cis-acting signals for replication, were used as baits for
RNA afﬁnity protein puriﬁcation. Ten proteins were preferentially pulled downwith either the 5′ or 3′ ends of
the genome and identiﬁed by proteomic analysis. Nine of them, including members of the heterogeneous
ribonucleoprotein family of proteins (hnRNPs), the poly(A)-binding protein (PABP), the p100 transcriptional
co-activator protein and two aminoacyl-tRNA synthetases, showed a preferential binding to the 3′ end of the
genome, whereas only the polypyrimidine tract-binding protein (PTB) was preferentially pulled down with
the 5′ end of the genome. The potential function of the 3′ end-interacting proteins in virus replication was
studied by analyzing the effect of their silencing using a TGEV-derived replicon and the infectious virus. Gene
silencing of PABP, hnRNP Q, and glutamyl-prolyl-tRNA synthetase (EPRS) caused a signiﬁcant 2 to 3-fold
reduction of viral RNA synthesis. Interestingly, the silencing of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), initially used as a control gene, caused a 2 to 3-fold increase in viral RNA synthesis in both systems.
These data suggest that PABP, hnRNP Q, and EPRS play a positive role in virus infection that could be
mediated through their interaction with the viral 3′ end, and that GAPDH has a negative effect on viral
infection.© 2009 Elsevier Inc. All rights reserved.Introduction
Transmissible gastroenteritis virus (TGEV) is a member of the
Coronaviridae family, included in the Nidovirales order (Enjuanes et al.,
2000, 2008). Coronaviruses (CoVs) have been classiﬁed in three
different groups based on antigenic and genetic criteria. The most
extensively studied group members are the TGEV and the human
coronavirus (HCoV) 229E from group 1, the mouse hepatitis virus
(MHV) and the severe acute respiratory syndrome (SARS) virus
(SARS-CoV) from group 2, and the infectious bronchitis virus (IBV)
from group 3. CoV infections cause a variety of diseases relevant in
animal and human health, being of special relevance the SARS in
humans (Drosten et al., 2003; Perlman et al., 2000). After the SARS
outbreak in 2002 the interest to understand the molecular basis of
CoV replication increased and, as a result, in the last years more than.
rd University Begbroke Science
ll rights reserved.30 new CoVs have been identiﬁed with a broad host distribution
(Vijaykrishna et al., 2007).
CoVs contain the largest known single-stranded positive-sense
infectious RNA genomes, varying between 27 and 31 kb in length
(Enjuanes et al., 2008; Masters, 2006). The CoV genome resembles the
structure of most cellular mRNAs, containing a cap structure at the 5′
end, a poly(A) tail at the 3′ end, and 5′ and 3′ untranslated regions
(UTRs). The replicase gene, that occupies the 5′ two thirds of the
genome, includes two overlapping open reading frames (ORF 1a and
ORF 1b) that are translated into two large co-amino-terminal
polyproteins,pp1aandpp1ab, the secondoneexpressedbya ribosomal
frameshift mechanism (Brierley et al., 1989). Both polyproteins are
autoproteolytically cleaved into up to 16 mature products (nsp1 to
nsp16), which are believed to be part of the replication–transcription
complex (Ziebuhr et al., 2000). CoV replicase gene is extremely
complex and, besides the RNA-dependent RNA-polymerase and heli-
case activities, it encodes other enzymes less frequent or exclusive
amongRNAviruses (Masters, 2006; Snijder et al., 2003; Ziebuhr, 2005),
such as an endoribonuclease, a 3′–5′ exoribonuclease, a 2′-O-ribose
methyltransferase, a ribose ADP 1″ phosphatase, and a second RNA-
dependent RNA-polymerase (Imbert et al., 2006). In addition to the
305C. Galán et al. / Virology 391 (2009) 304–314replicase components, the viral nucleoproteinhas been shown toplaya
major role in CoV RNA synthesis (Almazán et al., 2004; Schelle et al.,
2005). The resulting virus-encoded replication–transcription complex
presumably associates with host-cell proteins to complete the
synthesis of viral RNA (Enjuanes et al., 2006; Masters, 2006).
To date, several cellular proteins have been identiﬁed on the basis
of their ability to interact in vitrowith cis-acting replication signals of
CoVs from group 2 (MHV and bovine CoV), including the polypyr-
imidine tract-binding protein (PTB) (Li et al., 1999), heterogeneous
nuclear ribonucleoproteins (hnRNPs) A1 and Q (Choi et al., 2004; Li et
al., 1997), mitochondrial aconitase (Nanda and Leibowitz, 2001), and
poly(A)-binding protein (PABP) (Spagnolo and Hogue, 2000). Of
these proteins, a functional effect on CoV RNA synthesis has been
described for the hnRNPA1 (Shen andMasters, 2001; Shi et al., 2000),
hnRNP Q (Choi et al., 2004) and PTB (Choi et al., 2002; Li et al., 1999).
However, no interaction or functional study with cellular proteins has
been reported for group 1 CoVs.
In this study, we identiﬁed a set of 10 host proteins preferentially
interacting with either the 5′ or 3′ ends of the TGEV genome by RNA
afﬁnity chromatography and mass spectrometry analysis. Among
these, the PTB was found to preferentially interact with the 5′ end of
the TGEV genome while a subset of 9 proteins, including several
hnRNPs (A1, A0, A2B1, Q, and U), the glutamyl-prolyl-tRNA synthetase
(EPRS), the arginyl-tRNA synthetase, the PABP, and the p100
transcriptional co-activator, showed a preferential binding to the 3′
end. The relevance of the 3′ end-interacting proteins on TGEV
infection was analyzed using RNA silencing approaches. A signiﬁcant
and highly reproducible reduction of 2 to 3-fold in RNA synthesis and
virus titer was evidenced after silencing the expression of PABP,
hnRNP Q and EPRS proteins, suggesting that these factors play a
positive role in TGEV infection. Interestingly, silencing of the control
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) caused a 2
to 3-fold increase in TGEV RNA synthesis and virus titer, suggesting
that this protein might have a role counteracting TGEV infection.
Results
Host proteins interacting with the 5′ and 3′ ends of TGEV genome
To identify host-cell proteins potentially involved in TGEV RNA
synthesis, a screening based on the binding to 5′ and 3′ TGEV RNA
genome ends was used. To this end, two synthetic RNAs containing the
ﬁrst 504nt of the 5′ endof the TGEVgenomeand the last 493nt of the 3′
end plus a poly(A) tail were biotin labeled during the in vitro
transcription and used as baits for an RNA afﬁnity protein isolation
(Fig.1). The lengthof the transcriptswas chosenbasedon the sequences
required for the ampliﬁcation of TGEV-derived defective RNAs (Escors
et al., 2003; Izeta et al., 1999; and unpublished results) and the biotin
labeling was random and spaced out in order to minimize interference
of the biotin groups with potential RNA structures.Fig. 1. Genetic structure of the TGEV genome and derived transcription templates. The bar o
boxes. The bars below the genome represent the transcription templates for the generation o
and the transcription templates is indicated by shadowed areas. The G nucleotides out of the
starting sites of transcription are indicated as +1. Numbers below the bars indicate genome
gene; 3a and 3b, non-structural genes 3a and 3b; E, envelope protein gene;M,membrane pro
poly(A); SP6p and T7p, SP6 and T7 promoters, respectively.The biotin labeled RNA baits were immobilized on a Streptavidin
Sepharose resin and incubatedwith cell extracts from infected porcine
ST and rodent BHK-pAPN (expressing TGEV receptor) cells that are
highly susceptible to TGEV infection. In order to facilitate protein
identiﬁcation in the databases, extracts from the human hepatoma-
derived cell line Huh-7, which is susceptible to the TGEV PUR46-C11
strain infection, were also used. RNA–protein complexes were isolated
by centrifugation, resolved by electrophoresis in denaturing precasted
gels and identiﬁed by mass spectrometry (Fig. 2A). From the pulled
downproteins, a low proportion showed a preferential binding for one
of the genome ends, that was reproduced formost of them in the three
cell lines (Fig. 2B). Three independent RNA pull down assays were
performed and all the proteins showing a preferential binding for one
of the TGEV genome ends were excised from the gels and identiﬁed by
mass spectrometry. A set of 10 proteins was reproducibly identiﬁed in
at least two out of three experiments with signiﬁcant MASCOT scores
(pN0.05). The percentage of protein identiﬁcations varied depending
on the species of origin and it was 100% for human, 70% for rodent and
60% for porcine proteins (Table 1). That was probably a consequence
of sequence variations with respect to the public database sequences
for these species.
Among the identiﬁed proteins, PTB was the only one showing a
preferential binding to the 5′ end of the genome, whereas nine
proteins were found to bind preferentially to the 3′ end (Fig. 2B and
Table 1). These proteins include several hnRNPs (A1, A0, A2B1, Q, and
U) involved in RNA processing andmetabolism, the translation factors
EPRS, arginyl-tRNA synthetase and PABP, and the p100 transcriptional
co-activator.
Identiﬁcation by Western-blot of host proteins differentially interacting
with TGEV genome ends
To further conﬁrm the preferential binding to one of the viral
genome ends observed in the pull down experiments, a Western-blot
analysis of the pulled down proteins from infected Huh-7 cell extracts
was performed using speciﬁc antibodies. A strong binding preference
for the 3′ end of the genome was conﬁrmed for the hnRNPs U, A1,
A2B1, and A0 proteins (Fig. 3A) while a moderate preference was
observed for the EPRS, PABP, p100 and hnRNP Q proteins (Fig. 3B). In
addition, a preferential interaction of the PTB with the 5′ end was also
conﬁrmed (Fig. 3C). In contrast, the viral nucleoprotein that was used
as a loading control, was pulled down with a similar efﬁciency with
both genome ends (Fig. 3D). Similar results were obtained with cell
extracts from ST or BHK-pAPN infected cells (data not shown).
Effect of silencing the expression of 3′ end-interacting proteins on TGEV
replicon activity
One of the initial steps of CoV RNA synthesis involves the speciﬁc
recognition of the viral 3′ end to synthesize the negative-strand RNA.n top represents the TGEV virus genome in which the different genes are illustrated as
f 5′ and 3′ RNA ends used in this study. The sequence relationship between the genome
boxes indicate additional non-viral sequences required for the in vitro transcription. The
positions. TGEVg, TGEV genome; L, leader; ORF 1a and ORF 1b, replicase genes; S, spike
tein gene; N, nucleoprotein gene; 7, non-structural gene 7; UTR, untranslated region; An,
Fig. 2. RNA afﬁnity isolation of proteins preferentially interacting with the ends of the TGEV genome. (A) Scheme of the RNA afﬁnity chromatography. (B) Proteins (600 μg) from
infected Huh-7, BHK-pAPN, and ST cell extracts were pulled down, separated by SDS-PAGE and stained with Coomassie blue. All the bands showing a preferential interaction for one
of the TGEV genome ends were excised (in both lanes and for the three cell lines) and analyzed bymass spectrometry. Differentially isolated proteins are listed and the band of origin
indicated by arrows for the Huh-7 cells. The equivalent differentially isolated proteins are represented with arrowheads of the same pattern for BHK-pAPN and ST cells. The hnRNPs
A1 and A2B1, which are not highlighted in the presented gel from infected STcell extracts, were clearly identiﬁed in other experiments (Table 1). Molecular size markers are shown in
kilodaltons.
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selected for further functional analysis. To evaluate the impact of these
host proteins on TGEV RNA synthesis, their expression in 293T cells
was knocked down with siRNAs and the effect on the TGEV replicon
activity was analyzed by evaluating the production of subgenomic
RNA 7 by real-time reverse transcription-PCR (Q-RT-PCR), in
comparison with mRNA 7 levels in cells transfected with a
commercially validated negative control siRNA (Ambion, Table 2).
To perform the silencing assays, human 293T cells were selected
because they are efﬁciently transfected, support the replication of
the TGEV replicon (Almazán et al., 2004), and because of the
availability of pre-designed siRNA sequences and gene expression
assays to monitor the silencing of human genes. Transfectionefﬁciency of siRNAs and silencing were initially optimized using a
Cy3-labeled validated-siRNA against the GAPDH gene, reaching
transfection efﬁciencies close to 100% and a reduction of 80% at
the mRNA level (data not shown). Synthetic siRNA duplexes against
the GAPDH (silencing positive control) and the candidate genes
were transfected twice into 293T cells to allow sustained mRNA
silencing for at least 70 h in order to achieve detectable silencing at
the protein level (Fig. 4A). Chemically modiﬁed siRNAs (Silencer
Select siRNA, Ambion) were used in order to reduce the dose of
transfected siRNAs and the potential off-target effects (Elmen et al.,
2005). In addition, two different siRNAs per target were tested
separately. Six hours after the second siRNA transfection, the TGEV
replicon was transfected and total RNA and protein were isolated at
Table 1
Proteins differentially isolated with the ends of the TGEV genome.
RNA bait Accesion no. Protein namea Functionb Mr Masses matched/
searched
Score/threshold/
databasec
Speciesd Ne
3′TGEV gi|4504445 hnRNP A1 RNA transport, processing,
and splicing
34289 11/32 107/70/m H, R, P 3
3′TGEV gi|4504447 hnRNP A2B1 RNA transport and splicing 36041 16/32 165/65/Hs H, R, P 3⁎
3′TGEV gi|5803036 hnRNP A0 RNA splicing 30993 5/18 76/65/Hs H, R 3
3′TGEV gi|3202000 hnRNP U RNA processing and splicing 91164 19/35 136/78/nr H, R, P 3⁎
3′TGEV gi|44888326 hnRNP Q (SYNCRIP) RNA processing and splicing 69818 27/66 321/76/nr H, R, P 3⁎
3′TGEV gi|693937 Polyadenylate binding protein (PABP) RNA splicing and stabilization 70671 9/13 84/69/m H 3⁎
3′TGEV gi|5803036 Glutamyl-prolyl tRNA synthetase (EPRS) Translation 172080 25/28 269/78/nr H, R, P 3⁎
3′TGEV gi|30583627 Arginyl-tRNA synthetase Translation 76129 17/84 111/76/nr H, P 2⁎
3′TGEV gi|60415925 staphylococcal nuclease domain containing 1;
p100 co-activator
Transcription and RNA
interference
102709 29/40 363/76/nr H, R 3
5′TGEV gi|131529 Polypyrimidine tract-binding protein 1 (PTB) RNA splicing 56671 1/1 82/50/nr H 2
a When alternative names are given, the one used in this study is shown in boldface.
b Biological process according to Gene Ontology.
c Mascot scores are given in boldface. Mascot threshold scores indicate the limit score fromwhich the identiﬁcationwas signiﬁcant (pb0.05). Searches were performed against the
NCBI database without restrictions (nr). In the indicated cases taxonomy was restricted to humans (Hs) or mammals (m).
d Different species in which the protein was identiﬁed in parallel experiments, coming from human Huh-7 (H), rodent BHK-pAPN (R) or porcine ST (P) cell extracts.
e Number of times that the proteinwas identiﬁed showing a clear binding preference for the indicated RNA bait. Asterisks indicate that the identiﬁcationwas conﬁrmed byMS/MS.
Fig. 3.Western-blot analysis of the pulled down proteins. Proteins from infected Huh-7
cell extracts were pulled downwith the TGEV 5′ and 3′ genome ends, separated in SDS-
PAGE gels and analyzed by immunoblotting with speciﬁc antibodies. (A) Cellular
proteins showing a strong preference for the 3′ end of the TGEV genome. (B) Cellular
proteins showing a binding preference for the 3′ end of the genome. (C). Preferential
binding of the PTB to the 5′ end of the genome. (D) Binding of the viral nucleoprotein to
the 5′ and 3′ ends of the TGEV genome, as a loading control of the pull down output. In
the case of hnRNPA1, hnRNPA2B1 and PTB, the different isoforms detected by the
corresponding antibodies are indicated with arrowheads.
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transfection, respectively) to evaluate silencing of the target gene
and the replicon activity (Fig. 4A). Efﬁciencies for the three
consecutive transfections, cell viability, and silencing window during
3 days prior to the phenotypic assay were optimized by studying
both mRNA and protein levels.
For further studies PABP, hnRNP Q, and EPRS proteins were chosen
because they showed good silencing efﬁciencies at both mRNA and
protein levels at times posttransfection in which good cell viability
(N95%) was observed (data not shown). The silencing window of
PABP, hnRNP Q, and EPRS at the mRNA level reached a maximum at
48 h after the ﬁrst transfection (data not shown) that was prolonged
at least until 102 h posttransfection (Fig. 4B). A reduction of 80% at the
RNA level was detected for the positive control gene GAPDH. In the
case of the target genes, the reduction in mRNA levels was dependent
on siRNA sequence and it was within 70–95% for at least one siRNA of
PABP and EPRS genes, and around 60% for both siRNAs of hnRNP Q
gene (Fig. 4B). Silencing at the protein level was evaluated at 102 h
after the ﬁrst transfection of the siRNAs. A reduction of about 50% for
hnRNP Q and between 65 and 85% for GAPDH, PABP and EPRS was
observed (Fig. 4C).
Viral mRNA 7 expression was quantiﬁed as a measure of replicon
activity at 36 and 48 h after the replicon transfection (90 and 102 h
after the ﬁrst siRNA transfection, respectively). A reproducible and
signiﬁcant reduction in replicon activity of 2 to 3-fold for PABP,
hnRNP Q, and EPRS gene silencing was observed in comparison to
reference levels from cells transfected with a validated negative
control siRNA (Fig. 4D), suggesting that these factors have an
important positive effect on replicon RNA synthesis. Reduction of
replicon activity was transient, showing a good correlation with the
lowest protein levels after silencing and a dose-depending effect in
relation to the silencing potency of different siRNA sequences
(Fig. 4D). Interestingly, a signiﬁcant increment of about 3-fold in the
replicon activity was observed after GAPDH silencing (Fig. 4D),
indicating that GAPDH has a negative effect on replicon RNA
synthesis. Although these effects were moderate, they were highly
reproducible and statistically signiﬁcant, and of similar magnitude
than those reported in other viral systems (Hara et al., 2009; Pettit
Kneller et al., 2009).
Effect of GAPDH, PABP, hnRNP Q and EPRS gene silencing on TGEV
replication
To analyze the impact of silencing the expression of selected genes
on TGEV RNA synthesis and infectious virus production, the humancell line Huh-7, which is susceptible to TGEV PUR46-C11 strain
infection, was used. As described for the replicon system, the
transfection efﬁciency of siRNAs and silencing were optimized in
Huh-7 cells using a Cy3-labeled validated-siRNA against the GAPDH
gene (data not shown). In addition, only the siRNAs providing higher
silencing efﬁciencies for each target gene were chosen to perform the
phenotypic assays (Table 2 and Fig. 4). Synthetic siRNAs were
transfected into Huh-7 cells by reverse transfection and at 48 h
posttransfection the cells were infected with the TGEV PUR46-C11
strain at a multiplicity of infection (MOI) of 5. A single siRNA
transfection step was sufﬁcient to achieve sustained mRNA and
detectable protein silencing at the times of the phenotypic analysis.
Total RNAwas isolated at 36 and 72 h postinfection (84 and 120 h after
transfection of the siRNAs, respectively) to evaluate silencing at the
mRNA level and viral RNA synthesis by Q-RT-PCR with speciﬁc
Taqman gene expression assays (Fig. 5A). Silencing efﬁciency at mRNA
level was within the 85–95% range for GAPDH, PABP, hnRNP Q, and
EPRS genes (Fig. 5B). Silencing at the protein level was evaluated at
Table 2
siRNAs used for gene silencing analysis.
siRNA IDa Gene symbol Full gene target name Ref. no.b siRNA sequence 5′→3′c
AM4623 Cy3-GAPDH Glyceraldehyde-3-phosphate dehydrogenase Commercial positive control, sequence not available
#4390843 NEG Control #1 Commercial negative control, sequence not available
#4390849 GAPDH Glyceraldehyde-3-phosphate dehydrogenase Commercial positive control, sequence not available
s25665 PABP Poly(A)-binding protein, cytoplasmic 1 #1 CCUAAAUGAUCGCAAAGUAtt
UACUUUGCGAUCAUUUAGGag
s25664 PABP Poly(A)-binding protein, cytoplasmic 1 #2 AUCCAUUGAUAAUAAAGCAtt
UGCUUUAUUAUCAAUGGAUtt
s20563 hnRNP Q (SYNCRIP) Synaptotagmin binding, cytoplasmic RNA interacting protein #1 GAACGAGUGAAGAAGUUAAtt
UUAACUUCUUCACUCGUUCca
s20564 hnRNP Q (SYNCRIP) Synaptotagmin binding, cytoplasmic RNA interacting protein #2 CAAUAGAGGUUAUGCGUUUtt
AAACGCAUAACCUCUAUUGag
s4767 EPRS Glutamyl-prolyl-tRNA synthetase #1 CGAUGUCAGCAUUUCCGUUtt
AACGGAAAUGCUGACAUCGtc
s4768 EPRS Glutamyl-prolyl-tRNA synthetase #2 CGUUAGAGCUGAUUUACGAtt
UCGUAAAUCAGCUCUAACGcg
a ID provided by the manufacturer (Ambion).
b Arbitrary reference numbers used in this study.
c Sense and antisense sequences are given in upper and lower rows, respectively. All the siRNAs used are synthetic duplexes of 21 nt with 2 nt-protruding 3′ ends (in lower case).
308 C. Galán et al. / Virology 391 (2009) 304–314120 h after siRNAs transfection, and a reduction higher than 65% was
observed for all tested proteins (Fig. 5C).
Viral RNA synthesiswas quantiﬁed at 36 and 72 h postinfection and
a signiﬁcant effect was observed at 72 h postinfection. This time point
correspondswithmaximumTGEV PUR46-C11 RNA synthesis in Huh-7
cells. Similar to the replicon system, a reproducible and signiﬁcant
reduction of 2-fold in the viral RNA synthesis was evidenced after
silencing of PABP, hnRNP Q and EPRS genes, in comparison with the
reference levels from cells transfected with a validated negative
control siRNA (Fig. 5D). In accordancewith the observationmadewith
the TGEV replicon, a signiﬁcant increment on viral RNA synthesis of
about 2-fold was observed upon GAPDH silencing (Fig. 5D). Virus
production was quantiﬁed at 72 h postinfection by titrating the
supernatants from silenced Huh-7 cells on ST cells. In agreement with
the effects observed in viral RNA synthesis, a reproducible reduction in
virus titers to 36–50%was observed in cells silenced for PABP, hnRNPQ
and EPRS genes, while a 340% increase was detected in cells silenced
for the GAPDH gene (Fig. 5D). These results indicate that the silencing
of PABP, hnRNP Q, EPRS, and GAPDH genes have a signiﬁcant impact
both on virus RNA synthesis and infectious virus production.
Discussion
RNA viruses have often evolved to subvert host-cell factors in favor
of their own gene expression (Ahlquist et al., 2003; Lai, 1998). During
the course of CoV infection, the interactions of speciﬁc RNA genome
motifs with viral or cellular components probably regulate the initial
replicase translation, the switch from translation to RNA synthesis and
packaging of progeny genomes. In previous studies in group 2 CoVs,
several cellular proteins interacting with different RNA domains at the
5′ or 3′ UTRs have been identiﬁed by UV-crosslinking and RNA afﬁnity
protein isolation approaches (Shi and Lai, 2005; Spagnolo and Hogue,
2000; Yu and Leibowitz, 1995). Nevertheless, limited studies have
been performed with group 1 CoVs. In this study a set of 10 cellular
proteins preferentially binding to the ﬁrst 500 nt from either the 5′ or
3′ ends of the TGEV genome was identiﬁed and the relevance in virus
infection of GAPDH and the 3′ end-interacting proteins PABP, hnRNP Q
and EPRS, was determined. Considering that the 3′ end is the initiation
site for replication that starts with the synthesis of the negative
strand, the proteins interacting with the 3′-cis-acting replication
signals could play a key role at the initial stage of RNA replication. In
addition to the critical role of both 5′ and 3′ genome ends in CoV
replication, the genome ends most likely also contain signals that
regulate the translation, transcription and RNA stability (Masters,
2006; Ziebuhr, 2005). Thus, the proteins identiﬁed in this study could
be involved in any of these processes.A high proportion of the identiﬁed proteins belong to the cellular
splicing machinery, including the PTB (hnRNP I), that was preferen-
tially puriﬁed with the 5′ TGEV genome end, and ﬁve other hnRNPs
(A1, A2B1, A0, U and Q) preferentially associated with the 3′ end.
Although these proteins are predominantly nuclear factors, most of
them can shuttle between the nucleus and the cytoplasm associated
to mRNA (Caudy et al., 2003; Ghetti et al., 1992; Mizutani et al., 2000;
Myer and Steitz, 1995; Pinol-Roma and Dreyfuss, 1993; Weighardt et
al., 1995). On the other hand, nuclear proteins could be translocated
to the cytoplasm during infection affecting viral replication, as
described for other cytoplasmic RNA viruses (Lai, 1998). An example
of this phenomenon was previously reported for the hnRNP A1 that
relocates during infection from the nucleus to the sites of MHV RNA
synthesis in the cytoplasm (Li et al., 1997). CoV transcription involves
the fusion of non-continuous sequences by a discontinuous RNA
synthesis mechanism different from conventional RNA splicing but
with the same end result. The participation of cellular splicing factors
could be critical for assisting this process during CoV transcription by
bringing distant RNA sequences in close proximity. Among these
splicing factors, PTB, hnRNP A1, and hnRNP Q have been previously
shown to interact with MHV genome ends and to be involved in viral
RNA synthesis (Choi et al., 2002, 2004; Li et al., 1999; Shen and
Masters, 2001; Shi et al., 2000, 2003). In this study, we have found
two additional splicing factors, hnRNP A2B1 and hnRNP A0,
speciﬁcally associated to the 3′ end of TGEV genome. In addition, a
preferential co-puriﬁcation of the hnRNP Q with the 3′ end of the
TGEV genome was observed, whereas the studies on MHV were
limited to interaction with the 5′ end UTR (Choi et al., 2004).
Furthermore, hnRNP Q silencing experiments showed a signiﬁcant
reduction in TGEV RNA synthesis and virus production in agreement
with the effects observed after hnRNP Q silencing in MHV infected
cells that produced a delay in viral RNA synthesis and syncytium
formation (Choi et al., 2004).
In this report, we have described the speciﬁc co-puriﬁcation of
p100 with the 3′ end of the TGEV genome. An interaction of the p100
with the equine arteritis virus nsp 1, which is essential for mRNA
synthesis, has been described (Tijms and Snijder, 2003), but no
functional studies were reported on the role of p100 on arterivirus
transcription.
PABP was speciﬁcally associated with the 3′ end of the TGEV
genome and its silencing caused a signiﬁcant reduction in viral RNA
synthesis that correlated with a detectable reduction in virus titers.
Binding of PABP to bovine CoV poly(A) tail had been previously
reported (Spagnolo and Hogue, 2000). Nevertheless, our studies
report the ﬁrst direct evidence of the effect of this protein in CoV RNA
synthesis. CoV genomes mimic cellular mRNAs and are presumed to
Fig. 4. TGEV replicon activity in 293T cells after silencing the expression of TGEV 3′ end-interacting proteins. (A) Experimental design. The bar on top represents the TGEV-derived
replicon (REP 2) that contains the 5′ and 3′ UTRs, the replicase (ORF 1a and ORF 1b), the nucleoprotein (N), and the 7 genes (Almazán et al., 2004). The time-line of the silencing and
phenotypic assay is represented below. The time points refer to hours after the ﬁrst transfection (hpt) of the siRNAs. 293T cells were transfected (T1) with either a validated negative
control siRNA, an siRNA against the GAPDH gene (silencing positive control), or the siRNAs against the target genes (Table 2), seeded over poly-lysine-treated 96-well plates, and re-
transfected with the same siRNAs (T2) before the transfection with the TGEV replicon (T3). The time points at which the RNA and proteins were extracted to evaluate the silencing
and replicon activity are also indicated. (B) Silencing of cellular genes at the mRNA level. The percentage of mRNA remaining after the silencing of target genes PABP, hnRNP Q and
EPRS or the control gene GAPDH was quantiﬁed by Q-RT-PCR, in comparison to reference levels from cells transfected with a validated negative control siRNA. Two different siRNA
sequences (#1 and #2) were transfected separately to silence each target gene. Time points as in panel A. (C) Silencing of cellular genes at the protein level. Total cellular proteinwas
extracted at 102 h after the ﬁrst transfection of the siRNAs and the silencing was evaluated by immunoblotting. The β-actin was used as loading control. NEG, 293T cells transfected
with a validated negative control siRNA (Table 2). (D) Replicon activity in silenced 293T cells. Total RNA was extracted at 36 and 48 h after the transfection of the TGEV replicon (90
and 102 h after the ﬁrst transfection of the siRNAs, respectively) and the accumulation of viral mRNA 7 was quantiﬁed by Q-RT-PCR. Levels of mRNA 7 are represented as the fold-
change in comparison to reference levels from cells transfected with a negative control siRNA. Only the time point (36 or 48 h after transfection of the replicon) inwhich the effect on
the replicon activity was the highest is shown. The experiment was performed three times and the data represent the average of triplicates. Standard deviation is indicated as error
bars.
309C. Galán et al. / Virology 391 (2009) 304–314translate their genomes in a cap and poly(A)-dependent manner. The
binding of cap-recognizing factors to the 5′ end and the interaction of
the PABP with the poly(A) tail, could circularize the viral genome for
translation. This mechanism would favor the recycling of ribosomes,
the selection of complete molecules as templates and the controlled
regulation of the switch between translation and RNA synthesis that
occurs in opposite directions.A novel ﬁnding of this study is the preferential association of
EPRS protein to the 3′ end of the TGEV genome and the reduction
in TGEV RNA synthesis and virus titers after silencing the
expression of this protein. Aminoacyl-tRNA synthetases are ancient
enzymes that catalyze the amino acid addition to cognate tRNAs
(Ibba and Soll, 2000). In vertebrates, these enzymes have acquired
features that are absent in ancestral forms including additional
Fig. 5. Effect of silencing the expression of 3′ end-interacting proteins on TGEV infection. (A) Time-line of the silencing and phenotypic assay in Huh-7 cells. The time points refer to
hours after siRNAs transfection (hpt). The cells were transfected with siRNAs against the target genes (T) (Table 2) and infected with the TGEV PUR46-C11 strain at 48 h
posttransfection. Total RNA and protein were recovered at the indicated times to analyze the silencing and the viral phenotype. (B) Analysis of candidate gene silencing at the mRNA
level in Huh-7 cells. The percentage of mRNA remaining after the silencing of control gene GAPDH and the target genes PABP, hnRNP Q and EPRS was quantiﬁed by Q-RT-PCR, in
comparison to reference levels from cells transfected with a validated negative control siRNA. (C) Silencing of candidate genes at the protein level. The silencing was evaluated at
120 h posttransfection by immunoblotting. The β-actin was used as loading control. NEG, Huh-7 cells transfected with a validated negative control siRNA (Table 2). (D) Virus RNA
synthesis and virus production in silenced Huh-7 cells. Total RNA was extracted at 36 and 72 h postinfection (84 and 120 h posttransfection, respectively) and the accumulation of
viral mRNA7 was quantiﬁed by Q-RT-PCR. Levels of mRNA 7 are represented as the fold-change in comparison to reference levels from cells transfected with a validated negative
control siRNA. Virus production was quantiﬁed by titration of the supernatants on ST cells. The ﬁgure shows the effect observed on RNA synthesis and virus production at 72 h
postinfectionwhen the phenotype was more evident. The experiment was performed three times and the data represent the average of triplicates. Standard deviation is indicated as
error bars.
310 C. Galán et al. / Virology 391 (2009) 304–314functions unrelated to aminoacylation (Jia et al., 2008; Sampath et
al., 2004). Aminoacyl-tRNA synthetases play key roles in different
viral systems, such as the packaging of primer tRNAs in retroviruses
(Cen et al., 2002) or catalyzing the aminoacylation of tRNA-like
domains at the 3′ end of some plant RNA viruses to control plant
virus replication (Dreher, 2008; Kohl and Hall, 1974). With our data,
it is possible to speculate that the binding of EPRS to a speciﬁc RNA
motif at the 3′ termini of the TGEV genome could be a strategy to
efﬁciently compete with cellular mRNAs for the translation
machinery by recruiting a key enzyme and providing the substrate
for protein synthesis.Silencing of GAPDH led to a positive effect on TGEV RNA synthesis
and virus production. Furthermore, an interaction of GAPDH with at
least the 5′ end of the TGEV genome has been identiﬁed (data not
shown), suggesting the possibility that the effect observed on RNA
synthesis and virus production could be mediated by this interaction.
GAPDH is a glycolytic enzyme that also has RNA-binding properties
and plays different roles by interacting with the RNA genome of
different viruses. GAPDH has been involved in suppression of cap-
independent translation in picornaviruses by destabilization of the
IRES structure (Yi et al., 2000), and is a member of the replicase
complex of tombusviruses, where it may regulate viral asymmetric
311C. Galán et al. / Virology 391 (2009) 304–314RNA synthesis (Wang and Nagy, 2008). Interestingly, a reduction in
GAPDH gene expression has been found in SARS-CoV infected cells
and in cells transfected with nsp1 (Kamitani et al., 2006; Wathelet
et al., 2007). In our study the positive effect on TGEV RNA synthesis
and virus production after GAPDH silencing is in agreement with a
possible role of GAPDH in counteracting viral infection.
The effects of silencing the cellular genes described in this work on
TGEV replicon activity were reproducible and statistically signiﬁcant
with two different siRNA sequences per gene andwere proportional to
the silencing potency of each siRNA sequence. The phenotypes
observed in the TGEV replicon system were also corroborated with
the infectious virus, conﬁrming that the effects observed were
reproducible, irrespective of the different experimental systems and
cell types. Furthermore, although the differences in viral RNA
synthesis and titers observed after the silencing of the host candidate
genes could be considered moderate, similar quantitative results have
been reported in other viral systems (Hara et al., 2009; Pettit Kneller
et al., 2009). Overall, our data suggest an effect of GAPDH, PABP,
hnRNP Q, and EPRS on TGEV RNA synthesis and virus production.
Materials and methods
Cells and viruses
Baby hamster kidney cells stably transformed with the porcine
aminopeptidase N gene (BHK-pAPN) to make them susceptible to
TGEV (Delmas et al., 1993) were grown in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 5% fetal bovine serum (FBS)
(Biowhittaker, Berviers, Belgium) and geneticin (1.5 mg/ml) as a
selection agent. Swine testis (ST) cells (McClurkin and Norman, 1966)
were grown in DMEM supplemented with 10% FBS. Human liver
derived Huh-7 cells were kindly provided by R. Bartenschlager
(University of Heidelberg, Germany) and were grown in DMEM
supplemented with 10% of heat-inactivated FBS. Human 293T cells
were grown in DMEM supplemented with 5% FBS. TGEV PUR46-MAD
strain (Sánchez et al., 1990) was used to infect BHK-pAPN and ST cells
and TGEV PUR46-C11 strain (Sánchez et al., 1999) to infect Huh-7
cells. Virus titration was performed on ST cell monolayers as
previously described (Jiménez et al., 1986).
DNA constructs
To generate a DNA template for the in vitro transcription of a precise
TGEV 5′ end, the plasmid pM33L-637G (Galán et al., 2005) that
contains the M33L minigenome was used as template to amplify the
ﬁrst 504 nt of the TGEV genome. The PCR was performed with the
oligonucleotides XmaI-SP6p-G-5′TGEV-VS that includes the SP6
promoter and 5′TGEV-504-RS (Table 3). The resulting amplicon was
puriﬁed with the QIAquick PCR Puriﬁcation kit (QIAGEN), precipitated
with 0.1 vol of sodium acetate 3M pH 5.2 and 2.5 vol of cold 100%Table 3
Oligonucleotides used for PCR ampliﬁcations and Q-RT-PCR analysis.
Oligonucleotidea Methodb Oligonucle
XmaI-SP6p-G-5′TGEV-VS PCR 5′TGEV cgcgCCCGG
5′TGEV-504-RS PCR 5′TGEV CACCAATG
XmaI-T7p-GGG-ORF7-VS PCR 3′TGEV cgcgCCCGG
HindIII-poly(A)-RS PCR 3′TGEV gccgAAGCT
TGEV-Leader-VS Q-RT-PCR mRNA 7 CGTGGCTA
TGEV-7(38)-RS Q-RT-PCR mRNA 7 AAAACTGT
TGEV mRNA 7 (TaqMan MGB probe) Q-RT-PCR mRNA 7 FAM-CGAA
a VS, virus sense. RS, reverse sense. MGB, minor groove binder group.
b PCR 5′ (or 3′) TGEV, PCR for ampliﬁcation of the TGEV genome ends to generate transcrip
viral subgenomic mRNA 7.
c Restriction endonuclease sites used for cloning are in italics. Additional sequences at
Transcription initiation sites are in brackets. Template sequence corresponding to the poly(ethanol (sodium acetate-ethanol precipitation), resuspended in Tris–
HCl 10 mM pH 7.5, and then used as template for the in vitro
transcription reactions. The last 493 nt at the 3′ end of TGEV genome
were ampliﬁed from the plasmid pM33L-637G using the oligonucleo-
tides XmaI-T7p-GGG-ORF7-VS (Table 3) that introduces the T7
promoter preceding the viral sequence and HindIII-poly(A)-RS
(Table 3) that includes a 25 nt poly(A) tail. The PCR amplicon was
digested with XmaI and HindIII and cloned into the same restriction
sites of the plasmid pM33L-637G to generate the plasmid pM33L-3′-
template. The plasmid pM33L-3′-templatewas linearizedwithHindIII,
deproteinized by phenol chloroform extraction, precipitated by
sodium acetate-ethanol precipitation, and resuspended in the reaction
buffer of the Mung Bean nuclease (New England Biolabs). In order to
generate a precise TGEVgenome3′ end, the linearized plasmidpM33L-
3′-templatewas then treatedwithMung Bean nuclease to degrade the
three-nucleotide single-strand extension generated after the HindIII
digestion, following the manufacturer's conditions. The template was
deproteinized by phenol chloroform extraction, precipitated by
sodium acetate-ethanol precipitation, resuspended in Tris–HCl
10 mM pH 7.5, and then used for the in vitro transcription reactions.
In all cases the PCR reactions were performed with the Platinum Pfx
DNA polymerase (Invitrogen) following the manufacturer's recom-
mended conditions. All cloning steps were checked by sequencing the
PCR-ampliﬁed fragments and cloning junctions.
The generation of the TGEV-derived replicon REP 2 has been
previously described (Almazán et al., 2004).
In vitro transcription
In vitro transcription reactions were performed from 1 μg of
linearized pM33L-3′-template or 200 ng of the PCR amplicon
containing the 5′TGEV end using the SP6/T7 Transcription kit
(Roche). Biotin-14-CTP (Invitrogen) was added at a ﬁnal concentra-
tion of 0.16 mM in a 1:6.25 ratio to unlabeled CTP. The transcription
reactions were incubated 2 h at 37 °C and treated with 10 U of DNaseI
during 30 min at 37 °C. The resulting transcripts were puriﬁed with
the RNeasy kit (QIAGEN) following the RNA cleanup protocol,
analyzed by denaturing electrophoresis in 1% (w/vol) agarose-2.2 M
formaldehyde gels and spectrophotometrically quantiﬁed.
Cell extracts
ST, BHK-pAPN and Huh-7 cells were grown in 15-cm diameter
dishes to conﬂuence and infected at a MOI of 10 with TGEV PUR46-
MAD (for ST and BHK-pAPN cells) or at a MOI of 5 with TGEV PUR46-
C11 (for Huh-7 cells). After an adsorption period of 1 h the inoculum
medium was replaced by fresh medium and the cell extracts were
prepared at 7 and 36 h postinfection with the TGEV PUR46-MAD and
PUR46-C11 viruses, respectively. The cells were thenwashedwith cold
PBS, scrapped off the plates, centrifuged at 1500 ×g for 10 min at 4 °C,otide sequence 5′→3′c Amplicon
GATTTAGGTGACACTATA(G)ACTTTTAAAGTAAAGTGAGTGTAGC 557 bp
ACGTAGTGATCCTTACG
GTAATACGACTCACTATA(G)GGATGCTGTATTTATTACAGTTTTAATC 545 bp
TTTTTTTTTTTTTTTTTTTTTTTTTGTATCACTATC
TATCTCTTCTTTTACTTTAACTAG
AATAAATACAGCATGGAGGAA
TCAAACGAGATGCT-MGB
tion templates. Q-RT-PCR mRNA 7, primers and probe used for the quantiﬁcation of the
the 5′ of the restriction site are in lower case. Transcription promoters are in bold.
A) is underlined.
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and stored at −80 °C. To generate cytoplasmic extracts, 4×107 cells
were pelleted and resuspended in 400 μl of the extraction buffer
[10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, protease
inhibitor cocktail (Roche)] at 4 °C by gentle pipetting, incubated at 4 °C
for 15 min, and after addition of 25 μl of 10% NP-40, vortexed
vigorously for 10 s and centrifuged at 13,000 ×g for 30 s. The
supernatant was collected and stored in 10% glycerol at−80 °C. Total
protein concentration was determined with the Coomassie Plus
Protein Assay (Pierce) and the extracts were aliquoted to avoid
repeated freeze/thaw cycles.
RNA afﬁnity chromatography
Cell extracts (600 μg) were diluted 1:1 in binding-washing (BW)
buffer (50 mM Tris–HCl pH 7.5, 150 mMNaCl, 5% glycerol, 0.01% NP-40)
and pre-cleared three times with 20 μl of Streptavidin Sepharose beads
(Streptavidin Sepharose High Performance, Amersham) during 4 h. All
the incubationswereperformedat4 °C in anorbital shaker andthebeads
were collected by centrifugation at 440×g. Biotinylated RNA (10 μg)was
diluted in 200 μl of RNA-binding buffer (5 mM Tris–HCl pH 7.5, 0.5 mM
EDTA,1MNaCl) and incubatedwith 20 μl of fresh Streptavidin Sepharose
beads during 1 h. The immobilized RNA was washed three times for
15minwith 200 μl of BWbuffer and then incubatedwith the pre-cleared
protein extract overnight. The RNA–protein complexes were washed
three times for 15 min with 200 μl of BW buffer, pulled down and
resuspended in 30 μl of NuPage Sample buffer (Invitrogen)by incubation
for 10 min at 65 °C. The beads were centrifuged and the supernatant
containing RNA interacting proteins was recovered and analyzed by
denaturing electrophoresis using NuPAGE 4–12% Bis-Tris gels andMOPS
SDS Running buffer (Invitrogen). The gels were washed three times in
deionized water, stained with Coomasie blue Simply Blue Safe Stain
(Invitrogen), and theprotein bands of interestwere excised from the gels
for their identiﬁcation by mass spectrometry.
Identiﬁcation of proteins by mass spectrometry
Excised protein bands were in-gel digested with sequencing grade
modiﬁed porcine trypsin (Promega). Peptides were extracted from gel
pieceswith 100 μl of 50% acetonitrile in 0.1% formic acid, dried by speed
vacuum centrifugation and frozen. Peptides were dissolved in 7 μl of
0.1% formic acid and analyzed on a Micromass Q-TOF Micro mass
spectrometer (Manchester, UK) coupled to a CAPLCHPLC systemat the
Oxford Central Proteomics Facility of the Sir William Dunn School of
Pathology of the University of Oxford (UK). Alternatively, protein
digestions were eluted in 0.5% of triﬂuoroacetic acid, dried by speed
vacuum centrifugation and resuspended in 4 μl of MALDI solution. A
0.8 μl aliquot of each peptide mixture was deposited and dried onto a
386-well OptiTOF™ plate (Applied Biosystems) and co-crystallized
with 0.8 μl of matrix solution (3 mg/ml CHCA in MALDI solution).
Sampleswere analyzed bymatrix-assisted laser desorption/ionization
time-of-ﬂightmass spectrometry in anABI 4800MALDI TOF/TOFmass
spectrometer (Applied Biosystems) at the Proteomics Facility of the
Biotechnology National Centre (CNB-CSIC) of Madrid (Spain). Data
were analyzedusingMassLynx4.0 (Micromass,Manchester, UK) or the
ABI 4000 series explorer Software v3.6 and searches were performed
with the MASCOT software v2.1 (Matrix Science) against the MSDB
from the non-redundant NCBI protein database with a mass tolerance
of 100 and 200 ppm. No restrictions were imposed for protein
molecular weight, although in some cases taxonomy restrictions for
the human or mammalian databases were included.
Silencing analysis using the TGEV replicon system
The transfection and silencing efﬁciencies of siRNAs were
optimized in human 293T cells using a Cy3-labeled positive controlsiRNA targeting the human GAPDH gene (Table 2). In the optimized
conditions, 293T cells were grown to 60% conﬂuence in 35-mm-
diameter plates and transfected with 15 nM of Silencer Select siRNAs
(Ambion, Table 2) and 7.2 μl of RNAiMax (Invitrogen) according to the
manufacturer's speciﬁcations. Cells were incubated at 37 °C for 24 h
and then trypsinized and seeded on 96-well plates treated with poly-
lysine at a conﬂuence of 4×104 cells per well. The cells were re-
transfected with 10 nM of siRNAs at 48 h after the ﬁrst transfection
and incubated for 5 h at 37 °C. In the case of EPRS siRNA #1 (Table 2),
doses of 50 and 25 nM (for the ﬁrst and second siRNA transfections,
respectively) were required to achieve an efﬁcient silencing and a
signiﬁcant effect on the TGEV replicon activity. Finally, the transfection
medium was discarded and the cells were transfected with 200 ng of
the TGEV-derived replicon REP 2 and 0.48 μl of Lipofectamine 2000
(Invitrogen) as previously described (Almazán et al., 2004). Total RNA
and protein were collected at 36 and 48 h after the replicon
transfection for further analysis.
Silencing analysis with the infectious TGEV
Human Huh-7 cells, susceptible to TGEV PUR46-C11 strain, were
selected to analyze the effect of silencing host candidate genes on
TGEV infection. After optimization of the transfection and silencing
using a Cy3-labeled positive control siRNA targeting the human
GAPDH gene (Table 2), the reverse transfection method was chosen.
Brieﬂy, for each well of a 24-well plate, 4.8×104 cells were incubated
in suspension with 10 nM of Silencer Select siRNAs (Ambion, Table 2)
and 2 μl of siPORT Amine (Ambion) diluted in 25 μl of Opti-MEM I
Reduced Serum Medium (GibcoBRL-Invitrogen). Then, cells were
plated onto each well using DMEM medium with 10% of heat-
inactivated FBS. Cells were incubated at 37 °C for 48 h and then
infected with the TGEV PUR46-C11 at a MOI of 5. Total RNA, protein
and cell supernatants were collected at 36 and 72 h postinfection for
further analysis.
Analysis of cellular gene expression and viral RNA synthesis
Cellular gene expression and viral RNA synthesis were quantiﬁed by
Q-RT-PCR. Total cDNA was synthesized with random hexamers from
100 ng of total RNA using the High Capacity cDNA Transcription kit
(Applied Biosystems). Cellular gene expression was analyzed using
TaqMan gene expression assays (Applied Biosystems) speciﬁc for
human hnRNP Q (Hs00749309_s1 synaptotagmin binding, cytoplasmic
RNA interacting protein), EPRS (Hs00270083_m1 Inventoried EPRS,
glutamyl-prolyl-tRNA synthetase), PABP (Hs00743792_s1 Inventoried
PABPC1, poly(A)-binding protein, cytoplasmic 1) or GAPDH
(Hs99999905_m1 Inventoried glyceraldehyde-3-phosphate dehydro-
genase) genes. To analyze viral RNA synthesis a custom TaqMan assay
(Applied Biosystems) speciﬁc for the TGEVmRNA 7 (Table 3) was used.
Datawere acquiredwith an ABI PRISM 7000 sequence detection system
(Applied Biosystems) and analyzed with ABI PRISM 7000 SDS version
1.0 software. Relative gene expression referred to cells treated with a
validated negative control siRNA (Ambion, Table 2). The data represent
the average of biological triplicates.
Western-blot analysis
Cell lysates or pulled down RNA-binding proteins were analyzed
by denaturing electrophoresis in NuPAGE 4–12% Bis-Tris gels with
MOPS SDS Running buffer (Invitrogen). Proteins were transferred to a
nitrocellulose membrane (Hybond-C Extra Nitrocellulose, Amersham
Biosciences) with a Bio-Rad Mini protean II electroblotting apparatus
at 100 V for 1 h in Bis-Tris transfer buffer (25 mM Bis-Tris, 25 mM
Bicine, 1 mM EDTA) containing 20% methanol. Membranes were
blocked for 1 h with 5% dried skimmed milk in TBS (20 mM Tris–HCl
pH 7.5, 150 mM NaCl) and then probed with speciﬁc antibodies.
313C. Galán et al. / Virology 391 (2009) 304–314Primary antibodies for hnRNP A1 (rabbit polyclonal E17), hnRNP Q
(mouse mAb I8E4:sc-56703), hnRNP A2B1 (goat polyclonal G-16:sc-
10036), and hnRNP A0 (goat polyclonal G-17:sc-16509) were
purchased from Santa Cruz Biotechnology. Antibodies for hnRNP U
(rabbit polyclonal ab20666), EPRS (rabbit polyclonal ab31531),
GAPDH (rabbit polyclonal ab9485), and β-actin (mouse mAb
ab8226) were purchased from Abcam. The hybridoma BB7 against
PTB and the p100 transcriptional co-activator guinea pig polyclonal
antiserum GP25 were purchased from the ATCC and Progen
Biotechnik, respectively. The PABP rabbit polyclonal antiserum was
kindly provided by Dra. Amelia Nieto (CNB-CSIC, Madrid). To detect
the TGEVN protein themousemAb 3DC10was used (Martín Alonso et
al., 1992). Bound primary antibodies were detected with horseradish
peroxidase-conjugated antibodies against the different species and
the Immobilon Western chemiluminescent substrate (Millipore),
following the manufacturer's recommendations.
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